A comparative assessment of efficacy for pain relief and quality of life between dienogest and combined oral contraceptive pills in endometriosis patients in Eastern India

In: MGM Journal of Medical Sciences · 2025 · vol. 12(2) , pp. 322–330 · doi:10.4103/mgmj.mgmj_113_25 · W4411930400
article OA: diamond CC0
AI-generated summary by claude@2026-06, 2026-06-06

Dienogest demonstrated superior pelvic pain reduction compared to combined oral contraceptive pills in Eastern Indian endometriosis patients after six months, with both treatments showing slight quality of life improvements.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Abstract Background: This study aimed to compare the effectiveness of dienogest (DNG) and combined oral contraceptive (COC) pills in alleviating pain among patients with endometriosis in Eastern India. Materials and Methods: A prospective, hospital-based, observational comparative study was conducted at R. G. Kar Medical College and Hospital in Kolkata, India, from March 2021 to August 2022. The study included two groups: Group A (dienogest 2 mg/day, n = 115) and Group B (combined oral contraceptive pills, Mala-N, n = 115). Pain levels were assessed using the Visual Analog Scale (VAS), and the quality of life (QoL) was evaluated with the Endometriosis Health Profile Questionnaire (EHP-5 PRO) after 3 and 6 months of treatment. Results: The mean age ± standard deviation was 32.57 ± 8.02 years in Group A and 32.89 ± 7.92 years in Group B. After 6 months, Group A showed a significant reduction in pelvic pain ( P = 0.001), whereas Group B did not experience a significant improvement ( P = 0.55). A significant difference in pain reduction was observed between the two groups after 6 months ( P = 0.0001). Both treatments resulted in slight improvements in the quality of life, but the difference between the groups was not statistically significant. Conclusion: Both dienogest and COC pills may assist in managing endometriosis-related pain and enhancing the quality of life, with dienogest showing superior pain relief. These medications appear to be safe and effective options for managing endometriosis.

My notes (saved in your browser only)

Outcome instruments

EHP-30 VAS-pain MUSA

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (29)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK